Your browser doesn't support javascript.
loading
Prognostic Value of CD123 in Acute Myeloid Leukemia Patients with Intermediate Risk in Normal Karyotype / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 1880-1884, 2020.
Article Dans Chinois | WPRIM | ID: wpr-879987
ABSTRACT
OBJECTIVE@#To investigate the expression of CD123 in patients with acute myeloid leukemia (AML) and its relationship between clinical features, concomitant fusion gene or gene mutation, efficacy and prognosis.@*METHODS@#365 patients with newly diagnosed AML (except M3) treated in the First Affiliated Hospital of Zhengzhou University were enrolled and retrospective analysis, and multi-parameter flow cytometry was performed to detect the expression of CD123 in myeloid leukemia cell population. CD123≥20% was defined as positive. Clinical features, concomitant fusion gene or gene mutation, efficacy and prognosis of CD123@*RESULTS@#The positive rate of CD123 in 365 newly diagnosed AML patients was 38.9%. Compared with the CD123@*CONCLUSION@#CD123 positive indicates that AML patients have higher tumor burden and are more difficult to reach remission. It is an independent risk factor for OS and EFS in patients with normal karyotype and intermediate risk, which is important to evaluate the prognosis of patients with AML without specific prognostic marker.
Sujets)
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Patients / Pronostic / Leucémie aigüe myéloïde / Études rétrospectives / Sous-unité alpha du récepteur à l'interleukine-3 / Caryotype / Mutation Type d'étude: Etude d'étiologie / Étude observationnelle / Étude pronostique / Facteurs de risque Limites du sujet: Humains langue: Chinois Texte intégral: Journal of Experimental Hematology Année: 2020 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Patients / Pronostic / Leucémie aigüe myéloïde / Études rétrospectives / Sous-unité alpha du récepteur à l'interleukine-3 / Caryotype / Mutation Type d'étude: Etude d'étiologie / Étude observationnelle / Étude pronostique / Facteurs de risque Limites du sujet: Humains langue: Chinois Texte intégral: Journal of Experimental Hematology Année: 2020 Type: Article